Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Thomas Jefferson University
Baylor College of Medicine
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
IGF Oncology, LLC
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Novartis
Merck Sharp & Dohme LLC
University of Alabama at Birmingham
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Celgene
Roswell Park Cancer Institute
West Virginia University
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Boston Children's Hospital
Fred Hutchinson Cancer Center
University of Arizona
Stanford University
Neovii Biotech
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
University of California, Davis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota